3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The genetic basis of the comorbidity between cannabis use and major depression

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background and aims

          While the prevalence of major depression is elevated amongst cannabis users, the role of genetics in this pattern of comorbidity is not clear. This study aimed to estimate the heritability of cannabis use and major depression, quantify the genetic overlap between these two traits, and localize regions of the genome that segregate in families with cannabis use and major depression.

          Design

          Family-based univariate and bivariate genetic analysis.

          Setting

          San Antonio, Texas, USA

          Participants

          Genetics of Brain Structure and Function study (GOBS) participants: 1,284 Mexican-Americans from 75 large multi-generation families and an additional 57 genetically unrelated spouses.

          Measurements

          Phenotypes of lifetime history of cannabis use and major depression, measured using the semi-structured MINI-Plus interview. Genotypes measured using ~1M single nucleotide polymorphisms (SNPs) on Illumina BeadChips. A sub-selection of these SNPs were used to build multipoint identity-by-descent matrices for linkage analysis.

          Findings

          Both cannabis use (h 2=0.614, p=1.00×10 −6, SE=0.151) and major depression (h 2=0.349, p=1.06×10 −5, SE=0.100) are heritable traits, and there is significant genetic correlation between the two (ρ g=0.424, p=0.0364, SE=0.195). Genome-wide linkage scans identify a significant univariate linkage peak for major depression on chromosome 22 (LOD=3.144 at 2cM), with a suggestive peak for cannabis use on chromosome 21 (LOD=2.123 at 37cM). A significant pleiotropic linkage peak influencing both cannabis use and major depression was identified on chromosome 11, using a bivariate model (LOD=3.229 at 112cM). Follow-up of this pleiotropic signal identified a SNP 20kb upstream of NCAM1 (rs7932341) that shows significant bivariate association (p=3.10×10 −5). However this SNP is rare (7 minor allele carriers) and does not drive the linkage signal observed.

          Conclusions

          There appears to be significant genetic overlap between cannabis use and major depression among Mexican-Americans, a pleiotropy that appears to be localized to a region on chromosome 11q23 that has been previously linked to these phenotypes.

          Related collections

          Author and article information

          Journal
          9304118
          2264
          Addiction
          Addiction
          Addiction (Abingdon, England)
          0965-2140
          1360-0443
          8 September 2016
          26 September 2016
          January 2017
          01 January 2018
          : 112
          : 1
          : 113-123
          Affiliations
          [1 ] Department of Psychiatry, Yale University School of Medicine, New Haven, CT
          [2 ] South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San Antonio & University of Texas of the Rio Grande Valley, Brownsville, TX
          [3 ] Department of Genetics, Texas Biomedical Research Institute, San Antonio, TX
          [4 ] Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX
          [5 ] Research Imaging Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX
          [6 ] South Texas Veterans Health System, 7400 Merton Minter, San Antonio, TX
          [7 ] Olin Neuropsychiatric Research Center, Institute of Living, Hartford Hospital, Hartford, CT
          Author notes
          [* ]Correspondence to Karen Hodgson Ph.D., Department of Psychiatry, Yale School of Medicine, New Haven, CT karen.hodgson@ 123456yale.edu
          Article
          PMC5148647 PMC5148647 5148647 nihpa810503
          10.1111/add.13558
          5148647
          27517884
          046d7429-3166-47a8-8a3e-b7512d05c32a
          History
          Categories
          Article

          Comments

          Comment on this article